Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=247"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=247

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00233324-14d6a3db",
        "title": "Lower Oxygen Saturation Target vs Higher Oxygen Saturation Target: Survival Without Severe Retinopathy of Prematurity (ROP) (Threshold Disease or the Need for Surgery)",
        "summary": "434 of 605 against 418 of 616; risk difference 3.9 points, 95% interval -1.3 to 9.0; NCT00233324, Surfactant Positive Airway Pressure and Pulse Oximetry Trial",
        "record": "/library/comparisons/NCT00233324-14d6a3db",
        "nct_id": "NCT00233324",
        "kind": "outcome",
        "participants": 1221,
        "risk_difference": {
          "value": 0.03878394332939783,
          "lower": -0.012733062960546222,
          "upper": 0.08997460416687708
        },
        "group_1": "434 of 605",
        "group_2": "418 of 616",
        "difference": "3.9 points",
        "interval": "-1.3 to 9.0",
        "trial_title": "Surfactant Positive Airway Pressure and Pulse Oximetry Trial"
      },
      {
        "id": "NCT02995733-deaths",
        "title": "PARTICS vs Usual Care: deaths from any cause",
        "summary": "3 of 609 against 4 of 611; risk difference -0.2 points, 95% interval -1.2 to 0.9; NCT02995733, Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief",
        "record": "/library/comparisons/NCT02995733-deaths",
        "nct_id": "NCT02995733",
        "kind": "deaths",
        "participants": 1220,
        "risk_difference": {
          "value": -0.0016205364701329487,
          "lower": -0.012291318163064351,
          "upper": 0.008645808382976282
        },
        "group_1": "3 of 609",
        "group_2": "4 of 611",
        "difference": "-0.2 points",
        "interval": "-1.2 to 0.9",
        "trial_title": "Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=248",
  "request_id": "S1M0RW2TAYH1dF75"
}